Skip to main content

Reply to F. Valcamonico et al.

Publication ,  Journal Article
Smith, MR; Halabi, S; Small, EJ
Published in: J Clin Oncol
November 10, 2014

Duke Scholars

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

November 10, 2014

Volume

32

Issue

32

Start / End Page

3685

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Imidazoles
  • Humans
  • Diphosphonates
  • Bone Neoplasms
  • Bone Density Conservation Agents
  • Adenocarcinoma
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Smith, M. R., Halabi, S., & Small, E. J. (2014). Reply to F. Valcamonico et al. J Clin Oncol, 32(32), 3685. https://doi.org/10.1200/JCO.2014.57.3808
Smith, Matthew R., Susan Halabi, and Eric J. Small. “Reply to F. Valcamonico et al.J Clin Oncol 32, no. 32 (November 10, 2014): 3685. https://doi.org/10.1200/JCO.2014.57.3808.
Smith MR, Halabi S, Small EJ. Reply to F. Valcamonico et al. J Clin Oncol. 2014 Nov 10;32(32):3685.
Smith, Matthew R., et al. “Reply to F. Valcamonico et al.J Clin Oncol, vol. 32, no. 32, Nov. 2014, p. 3685. Pubmed, doi:10.1200/JCO.2014.57.3808.
Smith MR, Halabi S, Small EJ. Reply to F. Valcamonico et al. J Clin Oncol. 2014 Nov 10;32(32):3685.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

November 10, 2014

Volume

32

Issue

32

Start / End Page

3685

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Imidazoles
  • Humans
  • Diphosphonates
  • Bone Neoplasms
  • Bone Density Conservation Agents
  • Adenocarcinoma
  • 3211 Oncology and carcinogenesis